Drugs by condition
Drugs approved for tuberculosis
Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
14
Still marketed, NDA or BLA
Drug classes
5
Novel drugs
7
New molecular entities and new biologics
In development
14
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for tuberculosis.
- Pretomanid (Pretomanid) · Mylan Ireland LTD NovelPriority reviewOrphanAug 14, 2019
- Sirturo (Bedaquiline Fumarate) · Janssen Therap NovelAccelerated approvalPriority reviewOrphanDec 28, 2012
- Orapred Odt (Prednisolone Sodium Phosphate) · Advanz Pharma Jun 1, 2006
- Priftin (Rifapentine) · Sanofi Aventis US NovelAccelerated approvalPriority reviewOrphanJun 22, 1998
- Pediapred (Prednisolone Sodium Phosphate) · Pai Holdings May 28, 1986
All approved drugs for tuberculosis, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 161 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Corticosteroid (3)
- Medrol Methylprednisolone · Pfizer · 1957
- Kenalog-40 Triamcinolone Acetonide · Apothecon · 1965
- Cortef Hydrocortisone · Pharmacia and Upjohn · 1952
Antimycobacterial (1)
- Pretomanid Pretomanid · Mylan Ireland LTD · 2019
Rifamycin Antimycobacterial (1)
- Priftin Rifapentine · Sanofi Aventis US · 1998
Adrenocorticotropic Hormone (1)
- Cortrosyn Cosyntropin · Amphastar Pharms INC · 1970
Class not listed in FDA's data (8)
- Sirturo Bedaquiline Fumarate · Janssen Therap · 2012
- Myambutol Ethambutol Hydrochloride · Kanchan Hlthcare · 1967
- Celestone Soluspan Betamethasone Acetate, Betamethasone Sodium Phosphate · Organon · 1965
- Orapred Odt Prednisolone Sodium Phosphate · Advanz Pharma · 2006
- Pediapred Prednisolone Sodium Phosphate · Pai Holdings · 1986
- Depo-Medrol Methylprednisolone Acetate · Pfizer · 1959
- Solu-Medrol Methylprednisolone Sodium Succinate · Pharmacia and Upjohn · 1959
- Solu-Cortef Hydrocortisone Sodium Succinate · Pharmacia and Upjohn · 1955
Drugs in development for tuberculosis
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- BCGPhase 38 trials
ImmunityBio, Inc. · Non-muscle Invasive Bladder Cancer (NMIBC), Papillary-Only Non-muscle-invasive Bladder Cancer, Tuberculosis
- MTBVACBBV169Phase 32 trials
Biofabri, S.L · Tuberculosis, Tuberculosis (TB)
- TB-PPDPurified Protein Derivative of TuberculinPhase 32 trials
Chengdu CoenBiotech Co., Ltd · Tuberculosis, Latent Tuberculosis Infection
- QuabodepistatOPC-167832, QBSPhase 31 trial
Otsuka · Rifampicin-Resistant Pulmonary Tuberculosis, Multidrug-Resistant Pulmonary Tuberculosis
- DelamanidPhase 22 trials
WestVac Biopharma Co., Ltd. · Tuberculosis, Multidrug Resistant Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis
- HRZERifampicin, Isoniazid, Pyrazinamide, Ethambutol combinationPhase 22 trials
Thirty Respiratory Limited · Pulmonary Tuberculoses, Tuberculosis Meningitis
- Alpe375Phase 21 trial
BioVersys AG · Tuberculosis Meningitis
- AlpE500Phase 21 trial
BioVersys AG · Tuberculosis Meningitis
- AlpE625Phase 21 trial
BioVersys AG · Tuberculosis Meningitis
- BNT164a1Phase 21 trial
BioNTech SE · Tuberculosis
- BNT164b1Phase 21 trial
BioNTech SE · Tuberculosis
- BTZ-043Phase 21 trial
GSK · Tuberculosis
- GSK3036656Phase 21 trial
GSK · Tuberculosis
- JDB0131Phase 21 trial
WestVac Biopharma Co., Ltd. · Tuberculosis, Multidrug Resistant Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis
More on tuberculosis: recruiting trials · published research
Related in infectious disease and vaccines: HIV · Hepatitis B · Hepatitis C · COVID-19 · Influenza · RSV · Urinary tract infection · Pneumonia · Skin infections · C. difficile infection
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.